These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12945474)

  • 41. [Cholesterol is still high. So what do we do now? Treatment of uncontrolled hypercholesterolaemia over a year].
    Tobias Ferrer J; Sanjuán Cortés R; Fàbrega Camprubí M; Bonet Selga L; Roses Circuns C; Boquer Arnó J
    Aten Primaria; 2002 Feb; 29(3):151-7. PubMed ID: 11879601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Do the patients we treat with hypolipemic drugs have a coronary risk?].
    Vilaseca Canais J; Buxeda Mestres C; Cámara Contreras C; Flor Serra F; Pérez Guinaldo R; Sánchez Viñas M
    Aten Primaria; 1997 Jun; 20(1):49-53. PubMed ID: 9303663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Four cases of tendinopathy in patients on statin therapy.
    Chazerain P; Hayem G; Hamza S; Best C; Ziza JM
    Joint Bone Spine; 2001 Oct; 68(5):430-3. PubMed ID: 11707010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision.
    Trifirò G; Alacqua M; Corrao S; Moretti S; Tari DU; Galdo M; ; Caputi AP; Arcoraci V
    Eur J Clin Pharmacol; 2008 Jun; 64(6):619-25. PubMed ID: 18213473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Appropriateness of lipid-lowering treatment and cardiovascular risk in patients with hypercholesterolemia].
    Segade Buceta XM; Dosil Díaz O
    Gac Sanit; 2002; 16(4):318-23. PubMed ID: 12106551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of diet and drugs in lowering serum cholesterol in the postmyocardial infarction patient.
    Schettler G
    Cardiovasc Drugs Ther; 1989 Jan; 2(6):795-9. PubMed ID: 2488094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The "Five Risks algorithm": an easy tool for cardiovascular risk estimation.
    Devroey D; Vandevoorde J
    Cent Eur J Public Health; 2009 Sep; 17(3):133-8. PubMed ID: 20020602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacoeconomics of lipid-lowering drugs.
    Smith DG
    Curr Atheroscler Rep; 2003 Jan; 5(1):67-72. PubMed ID: 12562545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guidelines accompanied by changes in reimbursement rules. Effects on lipid-lowering drug prescribing.
    Bjerrum L; Larsen J; Kragstrup J
    Scand J Prim Health Care; 2001 Sep; 19(3):158-62. PubMed ID: 11697556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypercholesterolemia: a look at low-cost treatment and treatment adherence.
    Flannery J; Raulerson A
    J Am Acad Nurse Pract; 2000 Nov; 12(11):462-6. PubMed ID: 11930385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of "group detailing" on the prescribing of lipid-lowering drugs: a randomized controlled trial in Swedish primary care.
    Diwan VK; Wahlström R; Tomson G; Beermann B; Sterky G; Eriksson B
    J Clin Epidemiol; 1995 May; 48(5):705-11. PubMed ID: 7730925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study.
    Bertolotti M; Franchi C; Rocchi MB; Miceli A; Libbra MV; Nobili A; Lancellotti G; Carulli L; Mussi C;
    Drugs Aging; 2017 Apr; 34(4):311-319. PubMed ID: 28299634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drugs for treatment of patients with high cholesterol blood levels and other dyslipidemias.
    Bays HE; Dujovne CA
    Prog Drug Res; 1994; 43():9-41. PubMed ID: 7855253
    [No Abstract]   [Full Text] [Related]  

  • 54. Selecting an appropriate and reimbursed anti-osteoporotic treatment option: a practical tool in the Belgian setting.
    Grootaert V; De Keulenaer J; Boonen S; Sermon A; Spriet I; Willems L
    Acta Clin Belg; 2012; 67(1):13-8. PubMed ID: 22480033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Guidelines for diagnosis and treatment of adult hyperlipidaemias. Consensus of the Belgian Lipid Club.
    Ducobu J; Daubresse JC
    Acta Clin Belg; 1994; 49(5):243-8. PubMed ID: 7992570
    [No Abstract]   [Full Text] [Related]  

  • 56. Costs of aspirin and statins in general practice.
    Drummond A; Kwok S; Morgan J; Durrington PN
    QJM; 2002 Jan; 95(1):23-6. PubMed ID: 11834769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Management of increased cholesterol values in general practice--results of a survey of established primary care physicians].
    Allhoff PG; Laaser U
    Klin Wochenschr; 1989 Nov; 67(22):1147-51. PubMed ID: 2586019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carcinogenicity of lipid-lowering drugs.
    Newman TB; Hulley SB
    JAMA; 1996 Jan; 275(1):55-60. PubMed ID: 8531288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New methods of stroke prevention in patients with chronic brain ischemia stages II-III, accompanied by hypercholesterolemia].
    Megdiatov RS; Arkhipov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; (Suppl 14):23-9. PubMed ID: 16184850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Efficacy of lipid-lowering treatment in the adult population at a health centre].
    Calvo Cebrián A; Oquillas Izquierdo D; Cayuela Caravaca R
    Aten Primaria; 2003 Jan; 31(1):67. PubMed ID: 12570907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.